Chains & Business

New bill aims to support generic, biosimilar drug competitionThe CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development.
Insurers restricting high-risk opioid users to select pharmaciesAs the opioid epidemic continues to get worse, some health insurers are blocking patients identified as “high risk” from getting multiple opioid prescriptions filled at various pharmacies by restricting where they can fill prescriptions.
How one pharmacy survived the Baltimore riotsPharmacist Maisha McCoy will never forget those tense days in late April 2015, when rioting and looting were widespread throughout Baltimore.
Pharmacy leader treks across AmericaBruce Kneeland is on the hunt for unique indie pharmacies across the country.
Addressing the global disease burden: FIP 2016FIP's 76th annual World Congress of Pharmacy and Pharmaceutical Sciences takes place in Buenos Aires in August. This year's topic: The global disease burden.
Hilliard named 2017-2018 APhA president-electAPhA has announced its new officers for 2017-2018.
How pharmacists are helping patients kick the habitCVS decided to abandon tobacco sales in 2014. Plenty of community pharmacists were way ahead on that one.
Signs of a weakening pharmacist job marketAn expert with 35 years' academic and professional experience calls it like he sees it.
Patients, payers, and manufacturers’ drug couponsAccording to PBMs, those drug coupons are something else.
NCPA Congressional Pharmacy Summit advocates for clarity around Rx drug pricingMore than 300 pharmacists turned out to support H.R. 244, the “MAC Transparency Act," and H.R. 793, the “Ensuring Seniors Access to Local Pharmacies Act of 2015.”